PRESS RELEASE

from SARTORIUS STED BIO (EPA:DIM)

Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

16-Feb-2024 / 12:20 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

Company name: SARTORIUS STEDIM BIOTECH

Legal form: S.A.

 

2. Reason for the notification

 

The person making the disclosure is a closely associated person mentioned of article 3.26) of Regulation (EU) No 596/2014 of April 16, 2014 on market abuse.

 

Please give the identity and functions of the person with whom the reporting person has close personal ties.

 

Type of person/entity: Legal entity

Company name: SARTORIUS AG 

Position / status: Sartorius AG legal entity related to JOACHIM KREUZBURG, CHAIRMAN OF THE BOARD and RENE FABER, CEO

 

This notification is an initial notification.

 

3. Details of the issuer

 

Name: SARTORIUS STEDIM BIOTECH

LEI: 52990006IVXY7GCSSR39

 

4. Details of the transaction(s)

 

Date of the transaction: 2024/02/09

Place of the transaction: Euronext Paris

Nature of the transaction: Subscription

Description of the financial instrument, type of instrument: Share

Identification code: FR0013154002

 

Detailed operation information:

Unit price: EUR 233.00

Volume: 1,716,739 shares

 

Aggregated information:

Weighted average price: EUR 233.00

Volume: 1,716,739 shares

 

The transaction is NOT related to the exercise of a stock option program or to a bonus or performance share grant.

 

Date of receipt of the notification: 2024/02/14

 

5. Comments

 

Dr. Joachim Kreuzburg is the chairman of the Board of Directors of Sartorius Stedim Biotech S.A. and CEO of Sartorius AG. Dr. René Fáber is CEO of Sartorius Stedim Biotech S.A. and a member of the management board of Sartorius AG.


Regulatory filing PDF file

File: Directors' dealing notification_EN


Language:English
Company:Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone:+33 44 284 5600
E-mail:sartorius.presse@sartorius.com
Internet:www.sartorius-stedim.com
ISIN:FR0013154002
Euronext Ticker:DIM
AMF Category:Inside information / Other releases
EQS News ID:1839247
 
End of AnnouncementEQS News Service

1839247  16-Feb-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1839247&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
See all SARTORIUS STED BIO news